Table 5.

Cervical cancer: priorities in outpatient visits and staging

High priority	Medium	Low
Outpatient visits
Potentially unstable (acute abdominal symptoms, complications in the postsurgery recovery, complications during/after pelvic radiotherapy, renal obstruction). Symptomatic persistent severe bleeding from pelvic/vaginal ulcerated tumour. Anuria, symptoms of DVT in patients with confirmed diagnosis of cervical cancer. New histologically confirmed patient, no prior surgery, for staging workup (blood tests and imaging close to home if possible).	Postoperative patients with no complications. Established patients with new problems or symptoms from treatment—convert as many visits as possible to telemedicine appointments. Follow-up visit (clinical and pelvic examination) after palliative treatment for advanced/recurrent disease (postpone up to 2 months).	Follow-up visit (clinical and pelvic examination) after radical treatment for early disease (postpone up to 6 months). Survivorship visits off study.
Imaging
Bowel perforation, peritonitis. Postsurgery complications (perforation, anastomotic leak). Ureteral compression or hydronephrosis. Neurological symptoms suggesting nerve root/spinal involvement. Staging workup (if not done).	Tumour evaluation if clinical suspicion of tumour recurrence after radical treatment for early disease. Follow-up visit (with also clinical and pelvic examination) after palliative treatment for advanced/recurrent disease (postpone up to 2 months). Follow-up visits within a clinical study.*	Follow-up visits out of study (blood tests and imaging close to home, convert to telemedicine if possible).

*For patients on clinical trials, seek information about changes in management for individual studies from the coordinating trials unit for treatment frequency, blood investigations and imaging.

DVT, deep vein thrombosis